How to buy 89bio stock | $25.97

89bio, Inc is a biotechnology business based in the US. 89bio shares (ETNB) are listed on the NASDAQ and all prices are listed in US Dollars. 89bio employs 25 staff and has a market cap (total outstanding shares value) of USD$540.5 million.

How to buy shares in 89bio

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for 89bio. Find the stock by name or ticker symbol: ETNB. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until 89bio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$25.97, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of 89bio, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of 89bio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

89bio share price

Use our graph to track the performance of ETNB stocks over time.

89bio shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$25.97
52-week range	USD$14.0001 - USD$47.2532
50-day moving average	USD$26.5882
200-day moving average	USD$28.1874
Wall St. target price	USD$59.88
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-4.5598

Buy 89bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy 89bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of 89bio, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

89bio price performance over time

Historical closes compared with the close of $25.97 from 2020-12-18

1 week (2021-01-15)	21.47%
1 month (2020-12-23)	-2.88%
3 months (2020-10-22)	6.17%
6 months (2020-07-22)	-21.64%

1 year (2020-01-22)	-7.94%
2 years (2019-01-19)	N/A
3 years (2018-01-19)	N/A
5 years (2016-01-19)	N/A

89bio financials

Gross profit TTM	USD$0
Return on assets TTM	-24%
Return on equity TTM	-49.78%
Profit margin	0%
Book value	N/A
Market capitalisation	USD$540.5 million

TTM: trailing 12 months

Shorting 89bio shares

There are currently 539,056 89bio shares held short by investors – that's known as 89bio's "short interest". This figure is 4.1% down from 561,819 last month.

There are a few different ways that this level of interest in shorting 89bio shares can be evaluated.

89bio's "short interest ratio" (SIR)

89bio's "short interest ratio" (SIR) is the quantity of 89bio shares currently shorted divided by the average quantity of 89bio shares traded daily (recently around 136816.24365482). 89bio's SIR currently stands at 3.94. In other words for every 100,000 89bio shares traded daily on the market, roughly 3940 shares are currently held short.

However 89bio's short interest can also be evaluated against the total number of 89bio shares, or, against the total number of tradable 89bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 89bio's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 89bio shares in existence, roughly 30 shares are currently held short) or 0.0535% of the tradable shares (for every 100,000 tradable 89bio shares, roughly 54 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against 89bio.

Find out more about how you can short 89bio stock.

89bio share dividends

We're not expecting 89bio to pay a dividend over the next 12 months.

89bio overview

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treatment of severe hypertriglyceridemia. 89bio, Inc. was founded in 2018 and is based in San Francisco, California.

Frequently asked questions

• What percentage of 89bio is owned by insiders or institutions?

  Currently 0.595% of 89bio shares are held by insiders and 95.806% by institutions.

• How many people work for 89bio?

  Latest data suggests 25 work at 89bio.

• When does the fiscal year end for 89bio?

  89bio's fiscal year ends in December.

• Where is 89bio based?

  89bio's address is: 142 Sansome Street, San Francisco, CA, United States, 94104

• What is 89bio's ISIN number?

  89bio's international securities identification number is: US2825591033

• What is 89bio's CUSIP number?

  89bio's Committee on Uniform Securities Identification Procedures number is: 282559103